Copper, iron and zinc in Alzheimer's disease senile plaques

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported

Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,627

Rapid induction of Alzheimer A beta amyloid formation by zinc

Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296

Release of endogenous Zn2+ from brain tissue during activity

Assaf, S. Y., & Chung, S. (1984) · Nature · doi:10.1038/308734a0 · Cited by 1,113

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086

Alzheimer’s disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation

Wallin, C., Sholts, S. B., Österlund, N., Luo, J., Jarvet, J., Roos, P. M., Ilag, L. L., Gräslund, A., & Wärmländer, S. K. T. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-13759-5 · Cited by 116

Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers

Rana, M., & Sharma, A. K. (2018) · Metallomics · doi:10.1039/c8mt00203g · Cited by 116

Eukaryotic CTR Copper Uptake Transporters Require Two Faces of the Third Transmembrane Domain for Helix Packing, Oligomerization, and Function

Aller, S. G., Eng, E. T., Feo, C. J. D., & Unger, V. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409421200 · Cited by 112

Quantitative MR Imaging in Alzheimer Disease

Ramani, A., Jensen, J. H., & Helpern, J. A. (2006) · Radiology · doi:10.1148/radiol.2411050628 · Cited by 113

Alzheimer’ s disease, oxidative stress and gammahydroxybutyrate

Mamelak, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.008 · Cited by 108

Redox Processes of Methionine Relevant to β-Amyloid Oxidation and Alzheimer's Disease

Schöneich, C. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2621 · Cited by 115

Differential Effects of Apolipoprotein E Isoforms on Metal-Induced Aggregation of Aβ Using Physiological Concentrations

Moir, R. D., Atwood, C., Romano, D., Laurans, M. H., Huang, X., Bush, A. I., Smith, J. D., & Tanzi, R. E. (1999) · Biochemistry · doi:10.1021/bi982437d · Cited by 112

Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains

Kuhla, B., Boeck, K., Schmidt, A., Ogunlade, V., Arendt, T., Münch, G., & Lüth, H.-J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.007 · Cited by 108

β-Amyloid Fibrils in Alzheimer Disease Are Not Inert When Bound to Copper Ions but Can Degrade Hydrogen Peroxide and Generate Reactive Oxygen Species

Mayes, J., Tinker, C. L., Kolosov, O., Zhang, H., Tabner, B. J., & Allsop, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525212 · Cited by 110

Zinc dyshomeostasis: A key modulator of neuronal injury

Capasso, M., Jeng, J., Malavolta, M., Mocchegiani, E., & Sensi, S. L. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8202 · Cited by 110

Effects of Cyclen and Cyclam on Zinc(II)- and Copper(II)-Induced Amyloid β-Peptide Aggregation and Neurotoxicity

Chen, T., Wang, X., He, Y., Zhang, C., Wu, Z., Liao, K., Wang, J., & Guo, Z. (2009) · Inorganic Chemistry · doi:10.1021/ic900025x · Cited by 110

Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine

Horning, M. S., Blakemore, L. J., & Trombley, P. Q. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02215-5 · Cited by 109

Brain iron accumulation in aging and neurodegenerative disorders

Hagemeier, J., Geurts, J. J. G., & Zivadinov, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.128 · Cited by 114

Zinc Lowers Amyloid-β Toxicity by Selectively Precipitating Aggregation Intermediates

Garai, K., Sahoo, B., Kaushalya, S. K., Desai, R., & Maiti, S. (2007) · Biochemistry · doi:10.1021/bi700798b · Cited by 110

Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer’s and Vascular Dementia Drugs

Habtemariam, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020458 · Cited by 110

Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease

Kabir, M. T., Uddin, M. S., Zaman, S., Begum, Y., Ashraf, G. M., Bin-Jumah, M. N., BUNGAU, S. G., Mousa, S. A., & Abdel‐Daim, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02096-w · Cited by 113

Multifunctional Neuroprotective Derivatives of Rasagiline as Anti-Alzheimer's Disease Drugs

Weinreb, O., Mandel, S. A., Bar‐Am, O., Yogev‐Falach, M., Avramovich‐Tirosh, Y., Amit, T., & Youdim, M. B. H. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.030 · Cited by 111

Ternary Complexes of Iron, Amyloid-β, and Nitrilotriacetic Acid: Binding Affinities, Redox Properties, and Relevance to Iron-Induced Oxidative Stress in Alzheimer’s Disease

Jiang, D., Li, X., Williams, R. S., Patel, S., Men, L., Wang, Y., & Zhou, F. (2009) · Biochemistry · doi:10.1021/bi900907a · Cited by 111

Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?

Ferreira, M. E. S., de Vasconcelos, A. S., Vilhena, T. D. C., da Silva, T. L., Barbosa, A. D. S., Gomes, A. R. Q., Dolabela, M. F., & Percário, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0157-y · Cited by 111

Transition metal‐mediated glycoxidation accelerates cross‐linking of β‐amyloid peptide

Loske, C., Gerdemann, A., Schepl, W., Wycislo, M., Schinzel, R., Palm, D., Riederer, P. F., & Münch, G. W. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01452.x · Cited by 108

Zinc Fingers as Biologic Redox Switches?

Kröncke, K., & Klotz, L. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2269 · Cited by 113

Aluminium and iron, but neither copper nor zinc, are key to the precipitation of β-sheets of Aβ42 in senile plaque cores in Alzheimer's disease

Exley, C. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-305 · Cited by 107

Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer’s Disease

Prati, F., Cavalli, A., & Bolognesi, M. (2016) · Molecules · doi:10.3390/molecules21040466 · Cited by 110

Cu2+ Affects Amyloid-β (1–42) Aggregation by Increasing Peptide-Peptide Binding Forces

Hane, F. T., Tran, G., Attwood, S. J., & Leonenko, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059005 · Cited by 111

Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides

Aliès, B., Conte‐Daban, A., Sayen, S., Collin, F., Kieffer, I., Guillon, E., Faller, P., & Hureau, C. (2016) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.6b01733 · Cited by 108

In vivo study of the efficacy, biosafety, and degradation of a zinc alloy osteosynthesis system

Wang, X., Shao, X., Dai, T., Xu, F., Zhou, J. G., Qu, G., Tian, L., Liu, B., & Liu, Y. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.001 · Cited by 107

S100 family proteins in inflammation and beyond

Sreejit, G., Flynn, M., Patil, M., Krishnamurthy, P., Murphy, A. J., & Nagareddy, P. R. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.02.006 · Cited by 110

Light controlled receptors for heavy metal ions

Sahoo, P. R., Prakash, K., & Kumar, S. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.11.010 · Cited by 106

Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases

Cahill, C. M., Lahiri, D. K., Huang, X., & Rogers, J. T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.001 · Cited by 108

Metalloproteomics and metal toxicology of α-synuclein

Santner, A. A., & Uversky, V. N. (2010) · Metallomics · doi:10.1039/b926659c · Cited by 104

Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β Proteins

Murray, I. V. J., Liu, L., Komatsu, H., Uryu, K., Xiao, G., Lawson, J. A., & Axelsen, P. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608589200 · Cited by 106

A novel approach to the identification and quantitative elemental analysis of amyloid deposits—Insights into the pathology of Alzheimer’s disease

Rajendran, R., Minqin, R., Ynsa, M. D., Casadesús, G., Smith, M. A., Perry, G. L., Halliwell, B. B., & Watt, F. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.136 · Cited by 106

Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia–ischemia and stroke

Bishop, G. M., & Robinson, S. R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02303-4 · Cited by 104

The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk

Tanner, C. M., Goldman, S. M., Ross, G. W., & Grate, S. J. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.014 · Cited by 120

Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 118

Cellular Polyamines Promote Amyloid-Beta (Aβ) Peptide Fibrillation and Modulate the Aggregation Pathways

Luo, J., Yu, C., Yu, H., Borštnar, R., Kamerlin, S. C. L., Gräslund, A., Abrahams, J. P., & Wärmländer, S. K. T. S. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300170x · Cited by 103

Clues to Neuro-Degeneration in Niemann-Pick Type C Disease from Global Gene Expression Profiling

Reddy, J. V., Ganley, I. G., & Pfeffer, S. R. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000019 · Cited by 104

Luteolin Isolated from the Medicinal Plant Elsholtzia rugulosa (Labiatae) Prevents Copper-Mediated Toxicity in β-Amyloid Precursor Protein Swedish Mutation Overexpressing SH-SY5Y Cells

Liu, R., Meng, F., Zhang, L., Liu, A., Qin, H., Lan, X., Li, L., & Du, G. (2011) · Molecules · doi:10.3390/molecules16032084 · Cited by 103

Protection against amyloid beta peptide toxicity by zinc

Lovell, M. A., Xie, C., & Markesbery, W. R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01114-2 · Cited by 105

Neuronal and Vascular Oxidative Stress in Alzheimers Disease

Massaad, C. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376244 · Cited by 102

Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease

Masaldan, S., Belaidi, A. A., Ayton, S., & Bush, A. I. (2019) · Pharmaceuticals · doi:10.3390/ph12020093 · Cited by 106

Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients

House, M. J., Pierre, T. G. S., Kowdley, K. V., Montine, T. J., Connor, J. R., Beard, J., Berger, J., Siddaiah, N. B., Shankland, E. G., & Jin, L. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21118 · Cited by 105

Copper Promotes the Trafficking of the Amyloid Precursor Protein

Acevedo, K. M., Hung, Y. H., Dalziel, A. H., Li, Q., Laughton, K. M., Wikhe, K., Rembach, A., Roberts, B. R., Masters, C. L., Bush, A. I., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128512 · Cited by 109

Alterations of Zinc Transporter Proteins ZnT‐1, ZnT‐4 and ZnT‐6 in Preclinical Alzheimer's Disease Brain

Ganna Lyubartseva, A., Smith, J. L., Markesbery, W. R., & Lovell, M. A. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00283.x · Cited by 103

Selective destabilization of soluble amyloid β oligomers by divalent metal ions

Garai, K., Sengupta, P., Sahoo, B., & Maiti, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.056 · Cited by 102

Alzheimer’s Disease: Mechanism and Approach to Cell Therapy

Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 110

NMR Studies of the Zn 2+ Interactions with Rat and Human β-Amyloid (1−28) Peptides in Water-Micelle Environment

Gaggelli, E., Janicka-Kłos, A., Jankowska, E., Kozłowski, H., Migliorini, C., Molteni, E., Valensin, D., Valensin, G., & Wieczerzak, E. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp075168m · Cited by 102

Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management

Siddiqi, K. S., Husen, A., Sohrab, S. S., & Yassin, M. O. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2638-7 · Cited by 104

Biophysical Studies of the Amyloid β‐Peptide: Interactions with Metal Ions and Small Molecules

Wärmländer, S. K. T. S., Tiiman, A., Abelein, A., Luo, J., Jarvet, J., Söderberg, K. L., Danielsson, J., & Gräslund, A. (2013) · ChemBioChem · doi:10.1002/cbic.201300262 · Cited by 104

Deconvoluting the Cu2+ Binding Modes of Full-length Prion Protein

Klewpatinond, M., Davies, P., Bowen, S., Brown, D. R., & Viles, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708472200 · Cited by 102

Redox active metals in neurodegenerative diseases

Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 102

Altered microglial copper homeostasis in a mouse model of Alzheimer’s disease

Zheng, Z., White, C., Lee, J., Peterson, T. S., Bush, A. I., Sun, G. Y., Weisman, G. A., & Petris, M. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06888.x · Cited by 103

Zinc in Neurotransmission

Tóth, K. (2011) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145218 · Cited by 101

Oxidative Stress, Antioxidants, and Alzheimer Disease

Rottkamp, C. A., Nunomura, A., Raina, A. K., Sayre, L. M., Perry, G. L., & Smith, M. A. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00010 · Cited by 100

Is early-life iron exposure critical in neurodegeneration?

Hare, D. J., Arora, M., Jenkins, N. L., Finkelstein, D. I., Doble, P., & Bush, A. I. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.100 · Cited by 100

Copper mediated neurological disorder: Visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease

Ahuja, A., Dev, K., Tanwar, R. S., Selwal, K. K., & Tyagi, P. K. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.003 · Cited by 103

AMPA Receptors as Therapeutic Targets for Neurological Disorders

Lee, K., Goodman, L., Fourie, C., Schenk, S., Leitch, B., & Montgomery, J. M. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.10.004 · Cited by 106

Distinctive Pattern of Serum Elements During the Progression of Alzheimer’s Disease

Paglia, G., Miedico, O., Cristofano, A., Vitale, M., Angiolillo, A., Chiaravalle, A. E., Corso, G., & Costanzo, A. D. (2016) · Scientific Reports · doi:10.1038/srep22769 · Cited by 99

Amyloid-beta aggregation implicates multiple pathways in Alzheimer’s disease: Understanding the mechanisms

Iliyasu, M. O., Musa, S. A., Oladele, S. B., & Iliya, A. I. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1081938 · Cited by 106

Estrogen Decreases Zinc Transporter 3 Expression and Synaptic Vesicle Zinc Levels in Mouse Brain

Lee, J., Kim, J.-H., Hong, S. H., Lee, J. Y., Cherny, R. A., Bush, A. I., Palmiter, R. D., & Koh, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309730200 · Cited by 98

Copper-Targeting Approaches in Alzheimer’s Disease: How To Improve the Fallouts Obtained from in Vitro Studies

Esmieu, C., Guettas, D., Conte‐Daban, A., Sabater, L., Faller, P., & Hureau, C. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b00995 · Cited by 103

Aβ40, either Soluble or Aggregated, Is a Remarkably Potent Antioxidant in Cell-Free Oxidative Systems

Baruch-Suchodolsky, R., & Fischer, B. (2009) · Biochemistry · doi:10.1021/bi802361k · Cited by 98

Metal Binding of Alzheimer’s Amyloid-β and Its Effect on Peptide Self-Assembly

Abelein, A. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00370 · Cited by 105

Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial

Kessler, H., Bayer, T. A., Bach, D., Schneider-Axmann, T., Supprian, T., Herrmann, W., Haber, M., Multhaup, G., Falkai, P., & Pajonk, F. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0080-1 · Cited by 98

The Role of Hippocampal Iron Concentration and Hippocampal Volume in Age-Related Differences in Memory

Rodrigue, K. M., Daugherty, A. M., Haacke, E. M., & Raz, N. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs139 · Cited by 106

Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.

Brown, D. R. (2005) · PubMed · Cited by 98

Interplay of histidine residues of the Alzheimer’s disease Aβ peptide governs its Zn-induced oligomerization

Istrate, A., Kozin, S. A., Zhokhov, S. S., Mantsyzov, A. B., Kechko, O. I., Pastore, A., Makarov, A. А., & Polshakov, V. I. (2016) · Scientific Reports · doi:10.1038/srep21734 · Cited by 98

Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease

Jones, M. R., Mathieu, É., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Yong, V. W., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 97

Chelation therapy for neurodegenerative diseases

Bolognin, S., Drago, D., Luigi Messori, A., & Zatta, P. F. (2009) · Medicinal Research Reviews · doi:10.1002/med.20148 · Cited by 98

The amyloid‐β peptide and its role in Alzheimer's disease

Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 103

Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain

Zhang, L., Wang, X., Stoltenberg, M., Danscher, G., Huang, L., & Wang, Z. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.03.014 · Cited by 98

Hemoglobin promotes A? oligomer formation and localizes in neurons and amyloid deposits

Wu, C.-Y., LIAO, P., Yu, L., WANG, S., CHEN, S., Wu, C.-Y., & Kuo, Y. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.014 · Cited by 96

Interplay Between Mitochondrial Oxidative Disorders and Proteostasis in Alzheimer’s Disease

Llanos-González, E., Henares-Chavarino, Á. A., Pedrero-Prieto, C. M., García‐Carpintero, S., Frontiñán-Rubio, J., Sancho-Bielsa, F. J., Alcain, F. J., Peinado, J. R., Rabanal‐Ruiz, Y., & Durán‐Prado, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01444 · Cited by 99

Mechanisms by which metals promote events connected to neurodegenerative diseases

Campbell, A., Smith, M. A., Sayre, L. M., Bondy, S. C., & Perry, G. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00455-5 · Cited by 96

Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease

Robinson, S. R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10057 · Cited by 96

Heavy metals toxicity: effect of cadmium ions on amyloid beta protein 1–42. Possible implications for Alzheimer’s disease

Notarachille, G., Arnesano, F., Calò, V., & Meleleo, D. (2014) · BioMetals · doi:10.1007/s10534-014-9719-6 · Cited by 97

Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease

Anandatheerthavarada, H. K., & Devi, L. (2007) · The Neuroscientist · doi:10.1177/1073858407303536 · Cited by 95

Divalent metal transporter 1 is involved in amyloid precursor protein processing and Aβ generation

Zheng, W. H., Xin, N., Chi, Z., Zhao, B.-L., Zhang, J., Li, J., & Wang, Z. (2009) · The FASEB Journal · doi:10.1096/fj.09-135749 · Cited by 95

Quantitative susceptibility mapping of brain iron in healthy aging and cognition

Madden, D. J., & Merenstein, J. L. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120401 · Cited by 102

Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy

Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_8 · Cited by 96

α2-Macroglobulin and Haptoglobin Suppress Amyloid Formation by Interacting with Prefibrillar Protein Species

Yerbury, J. J., Kumita, J. R., Meehan, S., Dobson, C. M., & Wilson, M. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807242200 · Cited by 95

Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer’s disease

Chen, S., Chen, Y., Li, Y., Chen, S., Tan, J., Ou, T., Gu, L., & Huang, Z. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.033 · Cited by 95

Amyloid β Peptides Do Not Form Peptide-derived Free Radicals Spontaneously, but Can Enhance Metal-catalyzed Oxidation of Hydroxylamines to Nitroxides

Dikalov, S., Vitek, M. P., Maples, K. R., & Mason, R. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9392 · Cited by 97

Physiological Roles of Amyloid-?? and Implications for its Removal in Alzheimer???s Disease

Bishop, G. M., & Robinson, S. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421100-00001 · Cited by 94

Biogenic metallic elements in the human brain?

Everett, J., Lermyte, F., Brooks, J., Tjendana-Tjhin, V., Plascencia-Villa, G., Hands-Portman, I., Donnelly, J. M., Billimoria, K., Perry, G., Zhu, X., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf6707 · Cited by 94

The Metal Loading Ability of β-Amyloid N-Terminus: A Combined Potentiometric and Spectroscopic Study of Copper(II) Complexes with β-Amyloid(1−16), Its Short or Mutated Peptide Fragments, and Its Polyethylene Glycol (PEG)-ylated Analogue

Damante, C. A., Ösz, K., Nagy, Z., Pappalardo, G., Grasso, G., Impellizzeri, G., Rizzarelli, E., & Sóvágó, I. (2008) · Inorganic Chemistry · doi:10.1021/ic8006052 · Cited by 94

Effects of metals on the nervous system of humans and animals.

Carpenter, D. O. (2001) · PubMed · Cited by 94

Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer’s disease brain

Smith, J. L., Xiong, S., Markesbery, W. R., & Lovell, M. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.049 · Cited by 94

Brain Iron Metabolism and Neurodegenerative Disorders

Sipe, J. C., Lee, P. L., & Beutler, E. (2002) · Developmental Neuroscience · doi:10.1159/000065701 · Cited by 95

The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease

Drew, S. C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00317 · Cited by 93

Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer’s disease

Gomes, L. M., Bataglioli, J. C., & Storr, T. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213255 · Cited by 94

Stabilization of Neurotoxic Soluble β-Sheet-Rich Conformations of the Alzheimer's Disease Amyloid-β Peptide

Tew, D. J., Bottomley, S. P., Smith, D. P., Ciccotosto, G. D., Babon, J., Hinds, M. G., Masters, C. L., Cappai, R., & Barnham, K. J. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.119909 · Cited by 93

Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage alzheimer’s disease

Lovell, M. A., Smith, J. L., Xiong, S., & Markesbery, W. R. (2005) · Neurotoxicity Research · doi:10.1007/bf03033884 · Cited by 91

The S100B/RAGE Axis in Alzheimer's Disease

Leclerc, E., Sturchler, E., & Vetter, S. W. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/539581 · Cited by 99

Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer’s amyloid β-peptide (1–42)

Kański, J., Aksenova, M. V., Schöneich, C., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00821-3 · Cited by 94

In Vivo Visualization of Senile‐Plaque‐Like Pathology in Alzheimer's Disease Patients by MR Microscopy on a 7T System

Nakada, T., Matsuzawa, H., Igarashi, H., Fujii, Y., & Kwee, I. L. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00179.x · Cited by 92

How aluminum, an intracellular ROS generator promotes hepatic and neurological diseases: the metabolic tale

Han, S., Lemire, J. A., Appanna, V. D., Auger, C., Castonguay, Z., & Appanna, V. D. (2013) · Cell Biology and Toxicology · doi:10.1007/s10565-013-9239-0 · Cited by 95

Deciphering the Molecular Profile of Plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer’s Disease by Deep Sequencing

Bouter, Y., Kacprowski, T., Weissmann, R., Dietrich, K., Borgers, H., Brauß, A., Sperling, C., Wirths, O., Albrecht, M., Jensen, L. R., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00075 · Cited by 76

Lead (Pb) exposure and its effect on APP proteolysis and Aβ aggregation

Basha, M. R., Murali, M., Siddiqi, H. K., Ghosal, K., Siddiqi, O. K., Lashuel, H. A., Ge, Y., Lahiri, D. K., & Zawia, N. H. (2005) · The FASEB Journal · doi:10.1096/fj.05-4375fje · Cited by 74

Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer’s Disease and Nondemented Elderly Controls

Szabo, S. T., Harry, G. J., Hayden, K. M., Szabo, D. T., & Birnbaum, L. S. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv325 · Cited by 94

Zinc and Alzheimer's Disease: An Update

Cuajungco, M. P., Lees, G. J., Kydd, R. R., Tanzi, R. E., & Bush, A. I. (1999) · Nutritional Neuroscience · doi:10.1080/1028415x.1999.11747277 · Cited by 6

Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer’s Disease Correlates with Metal Levels in the Surrounding Neuropil

James, S., Churches, Q. I., de Jonge, M. D., Birchall, I. E., Streltsov, V. A., McColl, G., Adlard, P. A., & Hare, D. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00362 · Cited by 136

Elevated cortical zinc in Alzheimer disease

Religa, D., Strozyk, D., Cherny, R. A., Volitakis, I., Haroutunian, V., Winblad, B. G., Näslund, J., & Bush, A. I. (2006) · Neurology · doi:10.1212/01.wnl.0000223644.08653.b5 · Cited by 273

Association of trace elements Aluminum, Copper and Zinc in blood of Alzheimer's disease

Anwar, M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70860_107018

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress.

Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540